Marriage boosts survival odds for both men and women with colon cancer

NewsGuard 100/100 Score

A new study shows that being married boosts survival odds for both men and women with colon cancer at every stage of the disease.

Married patients had a 14 percent lower risk of death according to researchers at Penn State's College of Medicine and Brigham Young University. That estimate is based on analysis of 127,753 patient records.

Similar to studies of other types of cancers, the researchers did find that married people were diagnosed at earlier stages of colon cancer and sought more aggressive treatment. The researchers took those and other factors into account before calculating the benefit of marriage on survival odds.

"Controlling for the stage that the cancer was detected is key," said Sven Wilson, a study coauthor and professor at Brigham Young University. "Without that, it's hard to know whether the analysis is just picking up a diagnosis effect."

Colon cancer is the fourth most common type of cancer in the United States for both men and women. Curiously, the marriage benefit seen in the new study was nearly identical for both men and women.

So what's driving the different survival rates? Marriage is a self-selected group, and Wilson is careful to note that the selection process makes it difficult to sort out the root cause. One intuitive idea is that spouses serve as an important informal caregiver during a critical time, and that extra support may translate into better disease management and, hence, better outcomes..

Source: Brigham Young University

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New microfluidic device improves the separation of tumor cells and clusters from malignant effusions